The global leader in model-informed drug development and regulatory science, focused on optimizing drug development and improving health outcomes
Certara is the best-in-class provider of regulatory science, writing, and submission management software and services
- LandUnited States
- FondEQT VII
Certara is the leading provider of model-informed drug development technology and services, as well as a best-in-class provider of regulatory science, writing, and submission management software and services. Certara’s solutions help inform the drug development and regulatory approval process and address the key efficacy, safety, productivity and commercial challenges facing the biopharma industry. The Company serves 1,200 commercial companies, 250 academic institutions and numerous regulatory agencies, across 60 countries. Certara is headquartered in Princeton, New Jersey with over 850 employees globally, including key operations and senior management in Northern Europe.